These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31623245)

  • 1. Adapting to the Airways: Metabolic Requirements of
    La Rosa R; Johansen HK; Molin S
    Metabolites; 2019 Oct; 9(10):. PubMed ID: 31623245
    [No Abstract]   [Full Text] [Related]  

  • 2. Convergent Metabolic Specialization through Distinct Evolutionary Paths in Pseudomonas aeruginosa.
    La Rosa R; Johansen HK; Molin S
    mBio; 2018 Apr; 9(2):. PubMed ID: 29636437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid diversification of
    Schick A; Kassen R
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10714-10719. PubMed ID: 30275334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking Polymicrobial Metabolism in Cystic Fibrosis Airways:
    Gao B; Gallagher T; Zhang Y; Elbadawi-Sidhu M; Lai Z; Fiehn O; Whiteson KL
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29695623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Microevolution of Pseudomonas aeruginosa Differs between Mildly and Severely Affected Cystic Fibrosis Lungs.
    Klockgether J; Cramer N; Fischer S; Wiehlmann L; Tümmler B
    Am J Respir Cell Mol Biol; 2018 Aug; 59(2):246-256. PubMed ID: 29470920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marker genes for the metabolic adaptation of Pseudomonas aeruginosa to the hypoxic cystic fibrosis lung environment.
    Eichner A; Günther N; Arnold M; Schobert M; Heesemann J; Hogardt M
    Int J Med Microbiol; 2014 Nov; 304(8):1050-61. PubMed ID: 25130702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Shear Stress on Pseudomonas aeruginosa Isolated from the Cystic Fibrosis Lung.
    Dingemans J; Monsieurs P; Yu SH; Crabbé A; Förstner KU; Malfroot A; Cornelis P; Van Houdt R
    mBio; 2016 Aug; 7(4):. PubMed ID: 27486191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients.
    Marvig RL; Sommer LM; Jelsbak L; Molin S; Johansen HK
    Future Microbiol; 2015; 10(4):599-611. PubMed ID: 25865196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution in situ transcriptomics of Pseudomonas aeruginosa unveils genotype independent patho-phenotypes in cystic fibrosis lungs.
    Rossi E; Falcone M; Molin S; Johansen HK
    Nat Commun; 2018 Aug; 9(1):3459. PubMed ID: 30150613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of metabolic profiles of cystic fibrosis Pseudomonas aeruginosa during the early stages of lung infection.
    Jørgensen KM; Wassermann T; Johansen HK; Christiansen LE; Molin S; Høiby N; Ciofu O
    Microbiology (Reading); 2015 Jul; 161(7):1447-62. PubMed ID: 25873584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonal infection in cystic fibrosis: the battle continues.
    Elkin S; Geddes D
    Expert Rev Anti Infect Ther; 2003 Dec; 1(4):609-18. PubMed ID: 15482158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections.
    Behrends V; Ryall B; Zlosnik JE; Speert DP; Bundy JG; Williams HD
    Environ Microbiol; 2013 Feb; 15(2):398-408. PubMed ID: 22882524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition in Biofilms between Cystic Fibrosis Isolates of
    Oluyombo O; Penfold CN; Diggle SP
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696740
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
    Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
    BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.